Fundsmith LLP Terry Smith
London, X0 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $13.6B
- 41 holdings
- 2026 Q2
- +6.4% QoQ
- Top 5 29.8%
AUM over time
Book
| MAR, Marriott | Reduce −15.3% | 3,370,872 | $327.07 | $1.1B | −609,055 | −$132M | |
| SYK, Stryker | Reduce −17.0% | 3,061,416 | $328.59 | $1B | −626,095 | −$290M | |
| WAT, Waters | Reduce −9.7% | 3,212,075 | $297.80 | $957M | −345,903 | −$395M | |
| V, Visa | Reduce −12.2% | 3,104,090 | $302.24 | $938M | −430,594 | −$301M | |
| GOOGL, Alphabet | Reduce −15.5% | 2,956,198 | $287.56 | $850M | −542,321 | −$245M | |
| PM, Philip Morris International | Reduce −16.5% | 5,113,163 | $165.34 | $845M | −1,011,434 | −$137M | |
| IDXX, Idexx Laboratories | Reduce −21.9% | 1,465,786 | $561.89 | $824M | −410,249 | −$446M | |
| ADP, Automatic Data Processing | Reduce −7.7% | 3,855,105 | $203.18 | $783M | −322,864 | −$291M | |
| MSFT, Microsoft | Reduce 0.0% | 2,079,737 | $370.17 | $770M | −234 | −$236M | |
| META, Meta Platforms | Reduce −3.1% | 1,321,375 | $572.13 | $756M | −42,164 | −$144M | |
| MTD, Mettler-Toledo | Reduce −2.1% | 568,516 | $1,261 | $717M | −11,991 | −$92M | |
| CHD, Church & Dwight | Reduce −1.3% | 6,641,508 | $93.32 | $620M | −86,896 | +$56M | |
| PG, Procter & Gamble | Reduce −1.1% | 4,199,914 | $144.44 | $607M | −48,134 | −$2.2M | |
| TXN, Texas Instruments | Reduce 0.0% | 2,623,124 | $194.14 | $509M | −428 | +$54M | |
| FTNT, Fortinet | Reduce −5.5% | 6,156,675 | $81.72 | $503M | −359,336 | −$14M | |
| ZTS, Zoetis | Reduce −0.6% | 3,877,559 | $118.21 | $458M | −23,244 | −$32M | |
| OTIS, Otis Worldwide | Reduce −12.2% | 2,731,635 | $77.08 | $211M | −380,745 | −$61M | |
| MSCI | Reduce −61.1% | 64,788 | $539.01 | $35M | −101,831 | −$61M | |
| ROL, Rollins | Reduce −58.1% | 619,935 | $53.41 | $33M | −858,694 | −$56M | |
| MEDP, Medpace | Reduce −24.1% | 62,668 | $480.19 | $30M | −19,899 | −$16M | |
| VRSN, VeriSign | Reduce −58.1% | 113,467 | $248.36 | $28M | −157,167 | −$38M | |
| PAYC, Paycom Software | Reduce −58.1% | 219,457 | $121.54 | $27M | −303,976 | −$57M | |
| CLX, Clorox | Reduce −58.1% | 257,217 | $103.63 | $27M | −356,280 | −$35M | |
| VRT, Vertiv | Reduce −77.8% | 91,254 | $250.58 | $23M | −319,690 | −$44M | |
| NTNX, Nutanix | Reduce −58.1% | 577,392 | $38.01 | $22M | −799,766 | −$49M | |
| BMI, Badger Meter | New | 142,491 | $152.35 | $22M | +142,491 | +$22M | |
| Catalyst Pharmaceuticals | Reduce −74.9% | 844,887 | $24.76 | $21M | −2,518,920 | −$58M | |
| QLYS, Qualys | Reduce −65.1% | 226,077 | $87.85 | $20M | −421,729 | −$66M | |
| DOCS, Doximity | Reduce −58.1% | 691,786 | $23.30 | $16M | −958,216 | −$57M | |
| MANH, Manhattan Associates | Reduce −58.1% | 120,888 | $133.12 | $16M | −167,444 | −$34M | |
| NSSC, Napco Sec Technologies | Reduce −78.4% | 383,596 | $39.39 | $15M | −1,396,261 | −$59M | |
| ADMA, Adma Biologics | Reduce −21.5% | 1,649,493 | $9.01 | $15M | −452,561 | −$23M | |
| SABR, Sabre | Reduce −58.1% | 9,013,783 | $1.45 | $13M | −12,485,312 | −$16M | |
| HD, Home Depot | Reduce −64.3% | 28,611 | $328.89 | $9.4M | −51,595 | −$18M |
Exits / last held
Gone since 2025 Q4, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| INTU, Intuit | Exit | 0 | $662.42 | $414M | −625,619 | −$414M | |
| NKE, Nike | Exit | 0 | $63.71 | $368M | −5,770,181 | −$368M | |
| Holding | Exit | 0 | $40.18 | $83M | −2,074,167 | −$83M | |
| GGG, Graco | Exit | 0 | $81.97 | $47M | −579,016 | −$47M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 41 | $13.6B | +6.4% | 13F-HR | 8/14/2026 | 000156920526000012 |
| 2026 Q1 | 34 | $12.8B | −25.1% | 13F-HR | 5/15/2026 | 000156920526000005 |
| 2025 Q4 | 37 | $17.1B | −13.5% | 13F-HR | 2/17/2026 | 000156920526000002 |
| 2025 Q3 | 35 | $19.8B | −14.0% | 13F-HR | 11/14/2025 | 000156920525000004 |
| 2025 Q2 | 39 | $23B | +4.7% | 13F-HR | 8/14/2025 | 000180154725000008 |
| 2025 Q1 | 38 | $22B | −6.3% | 13F-HR | 5/15/2025 | 000152002325000003 |
| 2024 Q4 | 38 | $23.5B | −7.2% | 13F-HR | 2/14/2025 | 000152002325000002 |
| 2024 Q3 | 40 | $25.3B | +3.0% | 13F-HR | 11/14/2024 | 000152002324000040 |
| 2024 Q2 | 40 | $24.5B | −4.0% | 13F-HR | 8/14/2024 | 000152002324000030 |
| 2024 Q1 | 40 | $25.6B | +7.0% | 13F-HR | 5/15/2024 | 000152002324000020 |
| 2023 Q4 | 40 | $23.9B | +8.5% | 13F-HR | 2/14/2024 | 000152002324000014 |
| 2023 Q3 | 39 | $22B | −7.7% | 13F-HR | 11/14/2023 | 000152002323000012 |
| 2023 Q2 | 39 | $23.8B | +2.8% | 13F-HR | 8/14/2023 | 000152002323000011 |
| 2023 Q1 | 40 | $23.2B | +5.8% | 13F-HR | 5/15/2023 | 000152002323000010 |
| 2022 Q4 | 38 | $21.9B | +3.9% | 13F-HR | 2/14/2023 | 000152002323000001 |
| 2022 Q3 | 46 | $21.1B | −7.0% | 13F-HR | 11/14/2022 | 000152002322000010 |
| 2022 Q2 | 43 | $22.7B | −22.2% | 13F-HR | 8/15/2022 | 000152002322000009 |
| 2022 Q1 | 44 | $29.1B | −28.9% | 13F-HR | 5/16/2022 | 000152002322000006 |
| 2021 Q4 | 44 | $41B | +13.3% | 13F-HR | 2/14/2022 | 000186853722000005 |
| 2021 Q3 | 43 | $36.2B | — | 13F-HR | 11/12/2021 | 000152002321000007 |
About
Fundsmith LLP
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2